| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.6M | -4.7% |
| Cost of Revenue | $98.9M | +10.1% |
| Gross Profit | -$83.3M | -13.4% |
| R&D Expense | $22.8M | +21.6% |
| SG&A Expense | $60.0M | +11.9% |
| Operating Income | -$175.2M | -14.6% |
| Pre-tax Income | -$685.8M | -198.9% |
| Income Tax | $21K | -32.3% |
| Net Income | -$685.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $74.3M | +6.9% |
| Accounts Receivable | $3.0M | -10.3% |
| Inventory | $32.8M | +92.3% |
| Current Assets | $179.9M | +47.1% |
| Total Assets | $260.3M | +39.6% |
| Current Liabilities | $65.0M | +6.7% |
| Long-term Debt | $316.9M | +55.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$153.9M | -6.1% |
| Capital Expenditures | $33.2M | +13.1% |
| Investing Cash Flow | -$33.2M | -12.6% |
| Financing Cash Flow | $205.8M | -9.7% |
| Free Cash Flow | -$187.1M | -7.3% |
| -198.8% |
| EPS (Basic) | -$4.55 | -151.4% |
| EPS (Diluted) | -$4.55 | -151.4% |
| Total Liabilities |
| $842.1M |
| +183.3% |
| Stockholders' Equity | -$1.07B | -866.1% |